Breaking News on Contract Research, Manufacturing & Clinical Trials

Detailed market knowledge and an experienced CMO are still critical to successfully developing a biopharmaceutical or biosimilar according to Cobra Biologics.

Published: 25-Jan-2012

Sponsor and CRO perceptions of the quality of outsourced service provision differ markedly according to a study by consulting and survey research organisation, the Avoca Group.

Published: 08-Dec-2011

The global contract manufacturing market may be showing signs of recovery but careful investment and focusing on core activities is still the most sensible approach according to Sweden-based CDMO Recipharm.

Published: 05-Dec-2011

Contract services providers which embed service personnel in pharma companies are becoming more prominent in the industry.

Published: 21-Nov-2011

Almac says growing demand for non-GMP manufacturing work rather than competition was the key driver for expansion of its product development services business.

Published: 15-Nov-2011

Asking the right questions is key to giving pharmaceutical industry contract managers the information they need to select the best CRO partners according to the team behind a new performance assessment project.

Published: 09-Nov-2011

CMO Aenova says demand for contract manufacturing capacity in Europe is increasing.

Published: 31-Oct-2011

The human tissue supply industry is under pressure from CROs demanding more complex samples, according to equity analyst Vadim Alexandre.

Published: 27-Sep-2011

Pharma industry sponsors want more effective ways of measuring CRO performance according to the team behind a new project aiming to develop a validated set of analysis tools.

Published: 14-Sep-2011

Companies outsourcing patient recruitment in emerging markets should have more people on the ground, according to Cutting Edge Information's Shaylyn Pike.

Published: 31-Aug-2011

Companies looking to outsource patient recruitment need to think outside the box, says Cutting Edge Information’s director of research Eric Bolesh.

Published: 18-Aug-2011

Outsourcing should play a vital role in any patient recruitment strategy, says Cutting Edge Information’s director of research Eric Bolesh.

Published: 16-Aug-2011

An evidence-based approach to planning during protocol development is key to successful patient recruitment according to Joseph Kim, director of clinical operations at Shire Pharmaceuticals.

Published: 01-Aug-2011

INC Research CEO James Ogle tells Outsourcing-pharma.com that the acquisition of fellow CRO Kendle was about building a presence in emerging trial hotspots and pharmaceutical markets.

Published: 28-Jul-2011

Firecrest Clinical has launched a mobile version of its site management and training platform, citing investigator demand for ‘trial in your hand solutions’ and sponsor demand for increased research efficiency.

Published: 21-Jun-2011

Parexel CEO Josef von Rickenbach predicts more Big Pharma strategic partnerships.

Published: 06-Jun-2011

CRO and Pharma patient recruitment efforts can benefit from social networks and online patient groups, but clarification from the US FDA is still needed.

Published: 14-Mar-2011

The mix of materials in confidential biopharm waste is a recycling challenge but also an opportunity to cut “ever increasing” landfill costs.

Published: 09-Mar-2011

Contract packagers will lose deals if they fail to adapt to biopharm outsourcing “more and more” serialisation work, according to CEO of Covectra.

Published: 01-Mar-2011

Big pharma has taken a less heavy handed approach to relationships as cutbacks have made outsourcing key, according to Stephen Munk, CEO of Ash Stevens.

Published: 03-Feb-2011

Kerri Weingard, research director for Accumed, says the growing numbers of patients enrolling in multiple clinical trials are threatening the integrity of the clinical development process.

Published: 30-Nov-2010

Last week everything from co-processed excipients to Viagra-stuffed teddies were discussed at AAPS 2010. Now, with the show having finished, we present our personal take on the event.

Published: 22-Nov-2010

Almac invests $4m in biocatalysis R&D, describing such technologies as the way forward for the cost efficient production of highly chiral APIs and intermediates.

Published: 13-Oct-2010

Recipharm says changes to Big Pharma and drug industry globalisation make having a worldwide manufacturing reach a virtual necessity for CDMOs.

Published: 12-Oct-2010

Mark Weinstein, CEO of Bioclinica, has hit back at a public letter from Nicusa Capital CEO, Paul Johnson, claiming that the company's corporate strategy is 'flawed' and demanding the resignation of three top executives.

Published: 07-Oct-2010